| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 01/17/2006 | US6987120 Pharmaceutical compounds |
| 01/12/2006 | WO2006004884A2 Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors |
| 01/12/2006 | WO2006004833A2 Pyrrolotriazine kinase inhibitors |
| 01/12/2006 | WO2006004636A2 Fused heterocyclic kinase inhibitors |
| 01/12/2006 | WO2006002846A2 New analogs of nitrobenzylthioinosine |
| 01/12/2006 | US20060009642 Methods for the synthesis of substituted purines |
| 01/12/2006 | US20060008835 PNA monomer and precursor |
| 01/12/2006 | CA2571680A1 Fused heterocyclic kinase inhibitors |
| 01/11/2006 | EP1613628A2 Reversible inhibitors of s-adenosyl-l-homocysteine hydrolase and uses thereof |
| 01/11/2006 | EP1613612A2 Bioreductively-activated prodrugs |
| 01/11/2006 | EP0946557B1 A-1-adenosine receptor antagonists |
| 01/11/2006 | CN1720332A Substrates for O6-alkylguanine-DNA alkyltransferase |
| 01/11/2006 | CN1720246A (Purin-6-yl) amino acid and production method thereof |
| 01/10/2006 | US6984396 Conjugate having a cleavable linkage for use in a liposome |
| 01/10/2006 | CA2163520C L-2',3'-dideoxy nucleoside analogs as anti-hepatitis b (hbv) and anti-hiv agents |
| 01/05/2006 | WO2003031406A3 Kinase inhibitor scaffolds and methods for their preparation |
| 01/05/2006 | US20060004027 Drying process for preparing crystalline solid famciclovir |
| 01/05/2006 | US20060004006 Pyrrolotriazine kinase inhibitors |
| 01/05/2006 | US20060003374 Coupling amine terminated PNA oligomer or an amine terminated cleavable linker on a solid phase synthesis resin with a benzothiole-2-sulfonyl derivative, capping unprotected amine with actetic anhydride, cleaving over reacted acetyl group, deprotecting benzothiole-2-sulfonyl group, repeating above steps |
| 01/04/2006 | EP1612210A1 New analogs of nitrobenzylthioinosine |
| 01/04/2006 | EP1546391A4 Energy transfer dyes, terminators and use thereof |
| 01/04/2006 | EP1546125A4 Fluorescent labeling reagents with multiple donors and acceptors |
| 01/04/2006 | EP1169298B1 Pharmaceutical compounds |
| 01/03/2006 | US6982264 Enzyme inhibitors of beta-secretase-mediated cleavage of amyloid precuror proteins; congnition activators; Down's syndrome; Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-type; Parkinson's disease; hemostatic agents |
| 12/29/2005 | WO2005047524A3 Compositions and methods for inducing cell dedifferentiation |
| 12/29/2005 | US20050288503 Novel compounds |
| 12/29/2005 | US20050288290 e.g. 1-(4-(6-Chloro-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yloxy)-3-fluorophenyl)-3-(2-(4-fluorophenyl)acetyl)thiourea; mitogen-activated protein kinase inhibitor; anticarcinogenic agent, angiogenesis inhibitor; solid tumor, leukemia |
| 12/29/2005 | US20050288282 Anticancer agents; antiproliferative agents |
| 12/28/2005 | EP1608317A2 Dipeptidyl peptidase inhibitors |
| 12/28/2005 | EP1303641B1 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching |
| 12/28/2005 | EP0778836B1 Substituted 9-alkyladenines |
| 12/28/2005 | CN1714060A Method for deuteration or tritiation of heterocyclic ring |
| 12/28/2005 | CN1233644C Synthesis of 4-[[3-(1,6-dihydro-6-oxo-9H-purine-9-radical)-1-oxopropyl]amino] benzoic acid and its salt or ester |
| 12/27/2005 | US6979687 Theophylline-based soluble guanylyl cyclase activators KMUP-1 analogues enhanced cyclic GMP and K+ channel activities on rabbit corpus cavernosum smooth muscle and intercavernous pressure activities |
| 12/27/2005 | CA2243826C Synthesis of acyclic nucleosides |
| 12/27/2005 | CA2189271C Novel erythromycin derivatives, method for their preparation and their use as drugs |
| 12/22/2005 | US20050283005 A peptide nucleic acid derivatives comprising a N-acetyl-1-(2-nitro-phenensulfonyl)-peperazin-2-one core group; oligomerization, for specific binding to DNA as well as RNA, stability |
| 12/22/2005 | US20050282831 Adenine derivatives, especially substituted with an alkynylene-, alkenylene-, alkadienylene- or alkynylenealkenylene- group; e.g., 2-{3-[1-(Methoxycarbanoyl)piperidin-4-yl]propyn-1-yl}-9-propargyladenine; stimulating motor activity without dyskinesia; treating Huntington's & Parkinson's diseases, etc. |
| 12/22/2005 | US20050282802 double salts of N-(3-Methyl-benzylidene)-N'-[6-morpholin-4-yl-2-(2-pyridin-2-yl-ethoxy)-pyrimidin-4-yl]-hydrazine, having improved bioavailability, solubility, melting point and stability, used for the treatment of interleukin-12 (IL-12) related diseases or disorders |
| 12/22/2005 | US20050282768 Cardiovascular disease, a neurological disorder, an ischemic condition, a reperfusion injury, obesity, a wasting disease, or diabetes |
| 12/21/2005 | EP1102768B1 Substituted pyrazole derivatives condensed with six-membered heterocyclic rings |
| 12/21/2005 | CN1232521C Novel crystal form of 9-substituted hypoxanthine derivatives |
| 12/20/2005 | US6977300 A2B adenosine receptor antagonists |
| 12/20/2005 | CA2324324C Treatment of pulmonary hypertension |
| 12/20/2005 | CA2238516C Acyclic nucleoside derivatives |
| 12/15/2005 | WO2005118585A1 Process for the preparation of entecavir and novel intermediates thereof via carbon-silicon oxidation |
| 12/15/2005 | WO2005117910A2 Purine derivatives as adenosine a1 receptor agonists and methods of use thereof |
| 12/15/2005 | CA2569484A1 Process for the preparation of entecavir and novel intermediates thereof via carbon-silicon oxidation |
| 12/15/2005 | CA2567289A1 Purine derivatives as adenosine a1 receptor agonists and methods of use thereof |
| 12/14/2005 | CN1708499A Purine compounds and use thereof as cannabinoid receptor ligands |
| 12/14/2005 | CN1708498A Method for reducing residual alcohols in crystalline valacyclovir hydrochloride |
| 12/13/2005 | US6974808 CRF receptor antagonists and methods relating thereto |
| 12/13/2005 | US6974802 Treatment of viral infections using prodrugs of 2′,3-dideoxy,3′-fluoroguanosine |
| 12/08/2005 | WO2005116031A1 Drying process for preparing crystalline solid famciclovir |
| 12/08/2005 | WO2005058228A3 Comt inhibitors |
| 12/08/2005 | WO2005047526A3 Method for identifying inhibitors using a homology model of polo-like kinase 1 |
| 12/08/2005 | US20050272932 Process for the preparation of entecavir and novel intermediates thereof via carbon-silicon oxidation |
| 12/08/2005 | US20050272751 Inhibitors of Rho kinase; N-Benzyloxycarbonyl-4-[N''-(tert-butyloxycarbonyl)hydrazino]piperidine; 4-{[N''-(tert-butyloxycarbonyl)-N'-(1'-propyl)]hydrazino}piperidine |
| 12/08/2005 | US20050272745 Novel piperidine and piperazine derivatives |
| 12/08/2005 | US20050272676 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 12/08/2005 | US20050271715 Conjugate having a cleavable linkage for use in a liposome |
| 12/08/2005 | CA2566863A1 Purine derivative |
| 12/08/2005 | CA2566803A1 Drying process for preparing crystalline solid famciclovir |
| 12/07/2005 | EP1602657A2 Substituted 9-alkyladenines |
| 12/07/2005 | EP1601675A1 Purin-6-one-derivatives |
| 12/07/2005 | EP1601649A2 A1 adenosine receptor antagonists |
| 12/07/2005 | EP1216257B1 Compounds for the treatment of ischemia |
| 12/07/2005 | EP1171442B1 Xanthine derivatives and analogs as cell signalling inhibitors |
| 12/07/2005 | EP1017394B1 Cyclin dependent kinase inhibiting purine derivatives |
| 12/07/2005 | CN1230416C Pharmaceutical compounds |
| 12/06/2005 | CA2347512C Adenine derivatives |
| 12/06/2005 | CA2284774C Theobromine antitussive compositions |
| 12/01/2005 | WO2005113556A1 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta |
| 12/01/2005 | WO2005113554A2 Method of preparing 3-phenyl-2-[9h-purin-6-ylamino)-methyl]-3h-quinazolin-4-one and substituted and related compounds |
| 12/01/2005 | WO2005112938A2 Disalt inhibitors of il-12 production |
| 12/01/2005 | US20050267182 Urea derivatives as FLT-3 modulators |
| 11/30/2005 | EP1600448A2 Enantiomerically pure beta-D-(-)-Dioxolane-Nucleosides |
| 11/30/2005 | EP1599477A1 Sulfonamide substituted xanthine derivatives for use as pepck inhibitors |
| 11/30/2005 | EP1599474A2 Alternative heterocycles for dna recognition |
| 11/29/2005 | US6969766 PNA monomer and precursor |
| 11/29/2005 | US6969726 can be used as anti-proliferative agents and/or anti-infective agents that can be used without limitation as anti-inflammatory agents |
| 11/29/2005 | US6969720 2,6,9-trisubstituted purine derivatives which are inhibitors of cyclin/cdk (cyclin dependent kinases) complexes |
| 11/29/2005 | US6969713 Piperidine and piperazine acetamide derivatives |
| 11/24/2005 | US20050261317 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 11/24/2005 | US20050261316 Treatment of nervous system disorders, asthma and Alzheimers disease |
| 11/24/2005 | US20050261315 tyrosine kinase inhibitors such as N-(3-tert-butylisoxazol-5-yl)-2-(4-(benzyloxy)phenyl)acetamide, used for treating and preventing conditions and diseases, such as cancer, hematologic malignancies, cardiovascular disease, inflammation or multiple sclerosis |
| 11/24/2005 | US20050261269 New derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 11/24/2005 | US20050261242 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents; oxidative and endothelial stress dysfunction; free radicals scavenger |
| 11/23/2005 | EP1597258A2 Novel purine derivatives, preparation method thereof, application of same as medicaments, pharmaceutical compositions and novel use |
| 11/23/2005 | EP1597246A2 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 11/23/2005 | CN1699366A Purine derivatives |
| 11/23/2005 | CN1699365A Sodium entecavir and its preparation process and use |
| 11/23/2005 | CN1699364A Purine derivatives isomers, their preparation process and pharmaceutical compositions containing same |
| 11/23/2005 | CN1699350A Processes and intermediates for preparing anti-cancer compounds |
| 11/17/2005 | WO2005021044A3 Nanoparticles for delivery of nucleic acids and stable double-stranded rna |
| 11/17/2005 | US20050256143 Purine nucleosides |
| 11/17/2005 | US20050256142 New purine derivatives |
| 11/17/2005 | US20050256140 Condensed pyridines and pyrimidines with tie2 (tek) activity |
| 11/17/2005 | US20050256069 IRNA agents with biocleavable tethers |
| 11/17/2005 | US20050256034 Dioxolane analogs for improved inter-cellular delivery |